Mankind Pharma acquires Bharat Serums from Advent International for ₹13,630 crore. Learn More
Company
We are driven by three core values of quality, affordability and accessibility.
R&D & Innovation
With 6 cutting-edge R&D facilities, we pioneer breakthroughs like Dydragesterone in pharmaceutical excellence.
Safety & Sustainability
We have adopted policies aimed at complying with legislative requirements and ensuring the safety of our employees and the personnel working at our facilities or under our management.
International
Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society.
Investor Center
Mankind Pharma Ltd
NSE: MANKIND
-
-
Careers
Mankind Pharma is not just a workplace; it's a frontier of innovation. Join us in leveraging science to shape a healthier Bharat.
Shop
Discover more of Mankind
Close
Delivering healthcare solutions globally with a patient-centric approach
Mankind’s philosophy of innovative yet affordable healthcare is a universal need. So, it is no wonder that Mankind has been able to win hearts and markets in 35 countries across the globe through our core values of serviceability, transparency, and patient-centric values.
Products approved across 25+ countries
100+
Products approved across 25+ countries
Regulatory approvals Including USFDA, EU GMP, ANVISA, PIC/S, UAE
15+
Regulatory approvals Including USFDA, EU GMP, ANVISA, PIC/S, UAE
Niche Products in pipeline across Cardiovascular, Diabetology, Urology and Hormones
25+
Niche Products in pipeline across Cardiovascular, Diabetology, Urology and Hormones
Strong Presence
Strong Presence
In Women's Health, GYN, Gastroenterology, Anti-Diabetic, Cardiac and Anti-Infective
emerging market presence
Our Presence in
Overseas Market
Since its inception, Mankind aspires to be customer-centric and a leader in the Global markets. Committed towards a healthier and happier world, we strive to provide accessible and affordable healthcare to all sections of the society. Today, Mankind operates in 34 countries across the Globe.
Mexico
Mexico
Brazil
Brazil
Algeria
Algeria
Morocco
Morocco
South Africa
South Africa
UAE
UAE
Iraq
Iraq
Oman
Oman
Philippines
Philippines
Thailand
Thailand
Australia
Australia
China
China
Russia
Russia
United Kingdom
United Kingdom
Formulating business success
Formulating business success
Serviceability
Closer to the customer. Developing products as per market-specific needs.
Patient Centricity
Clear therapy-focused approach, targeting the Chronic Segments
Transparency
Mankind Corporate philosophy of better reach, Transparency & affordability
The emerging presence in Emerging Markets
Mankind’s innovative DNA comes to the fore in regulated emerging markets. Our pioneering R&D division has the capacity to develop niche molecules specific to emerging global markets. Over 26 products are currently in the pipeline at various stages of development, and more products are being regularly added.
The emerging presence in Emerging Markets
Know more about us
Home
About Us
R&D
Quality